TAXI/UAS: A molecular switch to control expression of genes in vivo

Human Gene Therapy

Volumn 7, Issue 7, 1996, Pages 809-820

  Delort, Jacques P ^a   Capecchi, Mario R ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; DRUG PROTEIN BINDING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE THERAPY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROMOTER REGION; RECOMBINANT GENE; REPORTER GENE; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 0029919753     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.7-809     Document Type: Article

References (50)

1. BAIM, S.B., LABOW, M.A., LEVINE, A.J., and SHENK, T. (1991). A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl-β-D-thiogalactopyranoside. Proc. Natl. Acad. Sci. USA 88, 5072-5076.
2. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
3. BAULIEU, E.-E. (1989). Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 245, 1351-1357.
4. BEATO, M. (1989). Gene regulation by steroid hormones. Cell 56, 335-344.
5. BECK, C.A., WEIGEL, N.L., MOVER, M.L., NORDEEN, S.K., and EDWARDS, D.P. (1993). The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA 90, 4441-4445.
6. BENHAMOU, B., GARCIA, T., LEROUGE, T., VERGEZAC, A., GOFFLO, D., BIGOGNE, C., CHAMBON, P., and GRONEMEYER, H. (1992). A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255, 206-209.
7. BLAU, H.M., DHAWAN, J., and PAVLATH, G.K. (1993). Myoblasts in pattern formation and gene therapy. Trends Genet. 9, 269-274.
8. BRAND, A.H., and PERRIMON, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.
9. BRASELMANN, S., GRANINGER, P., and BUSSLINGER, M. (1993). A selective transcriptional induction system for mammalian cells based on GAL4-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. USA 90, 1657-1661.
10. BROGDEN, R.N., GOA, K.L., and FAULDS, D. (1993). Mifepristone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45, 384-409.
11. BURNSTEIN, K.L., JEWELL, C.M., and CIDLOWSKI, J.A. (1990). Human glucoconicoid receptor cDNA contains sequences sufficient for receptor down-regulation. J. Biol. Chem. 13, 7284-7291.
12. CAPECCHI, M.R. (1994). Targeted gene replacement. Sci. Am. 270, 54-61.
13. CARSON, M.A., TSAI, M.J., CONNEELY, O.M., MAXWELL, B.L., CLARK, J.H., DOBSON, A.D., ELBRECHT, A., TOFT, D.O., SCHRADER, W.T., and O'MALLEY, B.W. (1987). Structure-function properties of the chicken progesterone receptor A synthesized from complementary deoxyribonucleic acid. Mo. Endocrinol. 1, 791-801.
14. CHRISTOPHERSON, K.S., MARK, M.R., BAJAJ, V., and GODOWSKI, P.J. (1992). Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophilia ecdysone receptor and chimeric transactivators. Proc. Natl. Acad. Sci. USA 89, 6314-6318.
15. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
16. DENG, C., and CAPECCHI, M.R. (1992). Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12, 3365-3371.
17. DENG, C., THOMAS, K.R., and CAPECCHI, M.R. (1993). Location of crossovers during gene targeting with insertion and replacement vectors. Mol. Cell. Biol. 13, 2134-2140.
18. ELLISTON, J.F., TSAI, S.Y., O'MALLEY, B.W., and TSAI, M.J. (1990). Superactive estrogen receptors. J. Biol. Chem. 265, 11517-11521.
19. EVANS, R.M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
20. FURTH, P.A., HENNIGHAUSEN, L., BAKER, C., BEATTY, B., and WOYCHICK, R. (1991). The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19, 6205-6208.
21. GARCIA, T., BENHAMOU, B., GOFFLO, D., VERGEZAC, A., PHILIBERT, D., CHAMBON, P., and GRONEMEYER, H. (1992). Switching agonistic, antagonistic, and mixed transcriptional responses to 11β-substituted progestins by mutation of the progesterone receptor. Mol. Endocrinol. 6, 2071-2078.
22. GILBERT, D.M., HEERY, D.M., LOSSON, R., CHAMBON, P., and LEMOINE, Y. (1993). Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol. 13, 462-472.
23. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MÜLLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
24. GREEN, S., and CHAMBON, P. (1988). Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4, 309-314.
25. GRONEMEYER, H. (1992). Control of transcription activation by steroid hormone receptors. FASEB J. 6, 2524-2529.
26. GU, H., MARTH, J.D., ORBAN, P.C., MOSSMAN, H., and RAJEWSKY, K. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
27. GUIOCHON-MANTEL, A., LOOSFELT, H., RAGOT, T., BAILLY, A., ATGER, M., MISRAHI, M., PERRICAUDET, M., and MILGROM, E. (1988). Receptors bound to antiprogestin form abortive complexes with hormone responsive elements. Nature 336, 695-698.
28. HORWITZ, K.B. (1985). The antiprogestin RU38486: Receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47D human breast cancer cells. Endocrinology 116, 2236-2245.
29. KANEKO, K.J., FURLOW, J.D., and GORSKI, J. (1993). Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol. Endocrinol. 7, 879-888.
30. KOZAK, M. (1990). Evaluation of the fidelity of initiation of translation in reticulocyte lysates from commercial sources. Nucleic Acids Res. 18, 2828.
31. MA, J., and PTASHNE, M. (1987). Deletion analysis of GAL4 defines two transcriptional activating segments. Cell 48, 847-853.
32. MCPHAUL, M.J., MARCELLI, M., TILLEY, W.D., GRIFFIN, J.E., and WILSON, J.D. (1991). Androgen resistance caused by mutations in the androgen receptor gene. FASEB J. 5, 2910-2915.
33. METZGER, D., CLIFFORD, J., CHIBA, H., and CHAMBON, P. (1995). Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92, 6991-6995.
34. MEYER, M.E., PORNON, A., JI, J., BOCQUEL, M.T., CHAMBON, P., and GRONEMEYER, H. (1990). Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 9, 3923-3932.
35. MULLICK, A., and KATZENELLENBOGEN, B.S. (1986). Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. J. Biol. Chem. 261, 13236-13243.
36. NAGY, A., ROSSANT, J., NAGY, R., ABRAMOW-NEWERLY, W., and RODER, J.C. (1993). Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428.
37. O'GORMAN, S., FOX, D.T., and WAHL, G.M. (1991). Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351-1355.
38. ORNITZ, D.M., MOREADITH, R.W., and LEDER, P. (1991). Binary system for regulating transgene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. USA 88, 698-702.
39. SADOWSKI, I., MA, J., TRIEZENBERG, S., and PTASHNE, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
40. SCHMIDT, E.V., CHRISTOPH, G., ZELLER, R., and LEDER, P. (1990). The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10, 4406-4411.
41. SEED, B., and SHEEN, J.Y. (1988). A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene 67, 271-277.
42. SELDEN, R.F., HOWIE, K.B., ROWE, M.E., GOODMAN, H.M., and MOORE, D.D. (1986). Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6, 3173-3179.
43. SHOCKETT, P., DIFILIPPANTONIO, M., HELLMAN, N., and SCHATZ, D.G. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522-6526.
44. THOMAS, K.R., and CAPECCHI, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
45. TSAI, M.J., and O'MALLEY, B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
46. VEGETO, E., ALLAN, G.F., SCHRADER, W.T., TSAI, M.J., MCDONNELL, D.P., and O'MALLEY, B.W. (1992). The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69, 703-713.
47. WANG, Y., O'MALLEY, B.W., JR, TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180-8184.
48. WHITE, J., BROU, C., WU, J., LUTZ, Y., MONCOLLIN, V., and CHAMBON, P. (1992). The acidic transcriptional activator GAL-VP16 acts on preformed template-commited complexes. EMBO J. 11, 2229-2240.
49. WHYATT, L.M., DUWELL, A., SMITH, A.G., and RATHJEN, P.D. (1993). The responsiveness of embryonic stem cells to alpha and beta interferons provides the basis of an inducible expression system for analysis of developmental control genes. Mol. Cell. Biol. 13, 7971-7976.
50. YAO, T.P., FORMAN, B.M., JIANG, Z., CHERBAS, L., CHEN, J.D., MCKEOWN, M., CHERBAS, P., and EVANS, R.M. (1993). Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366, 476-479.